Shares of Tatva Chintan Pharma Chem zoomed 20% to fresh 52 week high on Friday, July 25, in  a weak market . This growth follows the company's announcement of a robust financial performance for the first quarter of FY26, marked by a 27.7% increase in profit after tax, reaching Rs 6.7 crore compared to Rs 5.2 crore in the same period last year. The company's EBITDA also rose by 37.4% to Rs 17 crore from Rs 12.6 crore in Q1 of the previous fiscal. Operating margins expanded from 12% to 14.8% year-on-year. The results underscore the company's strategic initiatives to enhance operational efficiency and drive profitability, which have evidently paid off.